Unknown NA INTERVENTIONAL 2-arm NCT05125380

Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia

Evaluation of an Human Papillomavirus (HPV) Based Screening Algorithm for Low and Middle Income Countries, by Self-sampling in Ethiopia

Sponsor: Adama Hospital Medical College, Ethiopia

Conditions Cervical Cancer Human Papilloma Virus Microbiota STI

Interventions VIA (Visual Inspection with Acetic acid) VIA (Visual Inspection with Acetic acid) and VILI (Visual Inspection with Lugol's Iodine)

Updated 5 times since 2021 Last updated: Nov 1, 2023 Started: Dec 1, 2021 Primary completion: Oct 28, 2023 Completion: Sep 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cervical Cancer and Human Papilloma Virus and is currently ongoing. Adama Hospital Medical College, Ethiopia leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Dec 2023 — Jul 2024 [monthly]

Recruiting NA
Dec 2021 — Dec 2023 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Adama Hospital Medical College, Ethiopia
Addis Ababa University
Armauer Hansen Research Institute, Ethiopia
Lund University

Data source: Lund University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ādama, Ethiopia